GlassScriptPhysician profile
Sunil K Kottur
NPI 1346251139
$24,191.54
in general payments reported to CMS, 2019-2025
17 companies · $561 in 2025
The $561 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $1,454 · 2021: $3,741 · 2022: $813 · 2023: $706 · 2024: $586 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,853.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $18,754.22 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $1,902.95 | 2019-2024 | Jornay Pm |
| Sunovion Pharmaceuticals INC. | $700.70 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $524.79 | 2020-2022 | |
| Supernus Pharmaceuticals, INC. | $491.50 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $471.63 | 2021-2025 | Azstarys, Azstarys |
| Janssen Pharmaceuticals, INC | $412.25 | 2019-2024 | Spravato |
| Collegium Pharmaceutical, INC. | $188.73 | 2025 | Jornay Pm |
| Noven Therapeutics, LLC | $148.58 | 2023-2024 | Secuado |
| Vertical Pharmaceuticals, LLC | $125.63 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $120.48 | 2025 | Cobenfy |
| Noven Pharmaceuticals, INC. | $96.19 | 2023 | Xelstrym |
| Shire North American Group INC | $66.78 | 2019 | |
| Adlon Therapeutics L.P. | $66.38 | 2020-2021 | |
| Eisai INC. | $51.34 | 2022-2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rhodes Pharmaceuticals L.P. | $40.37 | 2019 | |
| Neos Therapeutics, LP | $29.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Kottur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.